Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcidion Group Limited (ALC) and Novartis AG (Six Swiss: CH:NOVN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alcidion Group Limited (AU:ALC – Research Report) and Novartis AG (CH:NOVN – Research Report).

Alcidion Group Limited (AU:ALC)

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Alcidion Group Limited on April 18 and set a price target of A$0.09. The company’s shares closed last Wednesday at A$0.05.

According to TipRanks.com, Wong-Pan is a 1-star analyst with an average return of -1.6% and a 45.7% success rate. Wong-Pan covers the Healthcare sector, focusing on stocks such as Nanosonics Limited, Ramsay Health Care, and Cochlear Limited.

Alcidion Group Limited has an analyst consensus of Moderate Buy, with a price target consensus of A$0.10.

See today’s best-performing stocks on TipRanks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AU:ALC:

• Alcidion Director Increases Shareholding
• Alcidion Group Reports Strong Q3 Sales and Cost Savings
• Alcidion Announces Q3 Results and Investor Webcast
• Alcidion Halts Millions of Performance Rights